US Patent 11192930 Ultra-long acting insulin-Fc fusion protein and methods of use
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+131 characters)
Article
Patent abstract
The present disclosure relates to compositions of insulin-Fc fusion proteins and their use to treat feline diabetes.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Thomas M. Lancaster0
Todd C. Zion0
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
111929300
Date of Patent
December 7, 2021
0Patent Application Number
172268470
Date Filed
April 9, 2021
0Patent Primary Examiner
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11192930 Ultra-long acting insulin-Fc fusion protein and methods of use
Infobox
Is a
Patent applicant
Patent jurisdiction
Patent number
11192930
Date of patent
December 7, 2021
Patent application number
17226847
Date Filed
April 9, 2021
Patent primary examiner
Find more entities like US Patent 11192930 Ultra-long acting insulin-Fc fusion protein and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
